EDIT: Have you ever looked at Altus? I am biased (a shareholder) one thing that attracted me is they do not change the underlying molecule with their crystallization technology. Allen Leon (sp?), David's partner at BSR, asked on one of the calls about forming antibody's for their PKU product (preclinical) and they seemed to think it was very unlikely because of how it is absorbed (if memory serves).